LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.93 | 27.76 | 385 | 4421 | 0.0871 | 0.4326 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.93 | 27.76 | 4058 | 4421 | 0.9178 | 0.9767 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 49.63 | 27.76 | 14 | 4818 | 0.0029 | -0.0879 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 49.63 | 27.76 | 4180 | 4818 | 0.8676 | 0.9622 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 49.63 | 27.76 | 499 | 4818 | 0.1036 | 0.4745 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 49.63 | 27.76 | 4295 | 4818 | 0.8914 | 0.9693 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 51.33 | 27.76 | 24 | 5117 | 0.0047 | -0.0191 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 51.33 | 27.76 | 4397 | 5117 | 0.8593 | 0.9601 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 51.33 | 27.76 | 549 | 5117 | 0.1073 | 0.4867 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 51.33 | 27.76 | 4591 | 5117 | 0.8972 | 0.9714 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.04 | 27.76 | 12 | 5365 | 0.0022 | -0.1046 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.04 | 27.76 | 4586 | 5365 | 0.8547 | 0.9591 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.04 | 27.76 | 588 | 5365 | 0.1096 | 0.4948 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.04 | 27.76 | 4861 | 5365 | 0.9059 | 0.9742 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 54.74 | 27.76 | 25 | 5606 | 0.0045 | -0.0136 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 54.74 | 27.76 | 4785 | 5606 | 0.8535 | 0.9590 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 54.74 | 27.76 | 603 | 5606 | 0.1076 | 0.4948 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 54.74 | 27.76 | 5068 | 5606 | 0.9039 | 0.9738 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 56.45 | 27.76 | 12 | 5745 | 0.0021 | -0.1033 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 56.45 | 27.76 | 5046 | 5745 | 0.8783 | 0.9665 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 56.45 | 27.76 | 621 | 5745 | 0.1081 | 0.4977 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 56.45 | 27.76 | 5313 | 5745 | 0.9247 | 0.9798 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.15 | 27.76 | 13 | 5906 | 0.0022 | -0.0934 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.15 | 27.76 | 5214 | 5906 | 0.8827 | 0.9680 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.15 | 27.76 | 590 | 5906 | 0.0999 | 0.4848 | MN20160318_Q01 | G16 |